These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Lassmann H. Exp Neurol; 2010 Sep; 225(1):2-8. PubMed ID: 19840788 [Abstract] [Full Text] [Related]
23. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Bö L, Geurts JJ, van der Valk P, Polman C, Barkhof F. Arch Neurol; 2007 Jan; 64(1):76-80. PubMed ID: 17210812 [Abstract] [Full Text] [Related]
24. Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis. Bagnato F, Ohayon JM, Ehrmantraut M, Chiu AW, Riva M, Ikonomidou VN. Expert Rev Neurother; 2006 Apr; 6(4):599-612. PubMed ID: 16623658 [Abstract] [Full Text] [Related]
25. Multiple sclerosis: what have we learned? Karceski S. Neurology; 2007 Feb 27; 68(9):E9-10. PubMed ID: 17325266 [No Abstract] [Full Text] [Related]
26. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M. Arch Neurol; 2007 Aug 27; 64(8):1163-8. PubMed ID: 17698707 [Abstract] [Full Text] [Related]
27. Gray matter involvement in patients with multiple sclerosis as shown by magnetic resonance imaging. Rumzan R, Chen X, Li YM. Chin Med J (Engl); 2012 Jul 27; 125(13):2361-4. PubMed ID: 22882862 [Abstract] [Full Text] [Related]
28. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study. Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B. Mult Scler; 2009 Feb 27; 15(2):204-11. PubMed ID: 18987104 [Abstract] [Full Text] [Related]
31. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis. Battaglini M, Giorgio A, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N. J Neurol Sci; 2009 Jul 15; 282(1-2):55-60. PubMed ID: 19286193 [Abstract] [Full Text] [Related]
33. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Mesaros S, Rovaris M, Pagani E, Pulizzi A, Caputo D, Ghezzi A, Bertolotto A, Capra R, Falautano M, Martinelli V, Comi G, Filippi M. Arch Neurol; 2008 Sep 15; 65(9):1223-30. PubMed ID: 18779427 [Abstract] [Full Text] [Related]
34. The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Lassmann H. Neuroimaging Clin N Am; 2008 Nov 15; 18(4):563-76, ix. PubMed ID: 19068402 [Abstract] [Full Text] [Related]
35. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study. Horakova D, Dwyer MG, Havrdova E, Cox JL, Dolezal O, Bergsland N, Rimes B, Seidl Z, Vaneckova M, Zivadinov R. J Neurol Sci; 2009 Jul 15; 282(1-2):112-9. PubMed ID: 19168190 [Abstract] [Full Text] [Related]
36. Visualizing the cause of gray matter atrophy in multiple sclerosis. Richert ND, Kraft E, Stüve O. Arch Neurol; 2009 Feb 15; 66(2):159-60. PubMed ID: 19204151 [No Abstract] [Full Text] [Related]
37. Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis. Bizzozero OA, DeJesus G, Callahan K, Pastuszyn A. J Neurosci Res; 2005 Sep 01; 81(5):687-95. PubMed ID: 16007681 [Abstract] [Full Text] [Related]
38. Texture analysis of magnetization transfer maps from patients with clinically isolated syndrome and multiple sclerosis. Tozer DJ, Marongiu G, Swanton JK, Thompson AJ, Miller DH. J Magn Reson Imaging; 2009 Sep 01; 30(3):506-13. PubMed ID: 19711400 [Abstract] [Full Text] [Related]
39. A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes. Zipp F. J Neurol Sci; 2009 Dec 01; 287 Suppl 1():S24-9. PubMed ID: 20106345 [Abstract] [Full Text] [Related]
40. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Ceccarelli A, Filippi M, Neema M, Arora A, Valsasina P, Rocca MA, Healy BC, Bakshi R. Mult Scler; 2009 Jun 01; 15(6):678-86. PubMed ID: 19482861 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]